Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Excellent outcome of allogeneic bone marrow transplantation for Fanconi anemia using fludarabine-based reduced-intensity conditioning regimen.

Shimada A, Takahashi Y, Muramatsu H, Hama A, Ismael O, Narita A, Sakaguchi H, Doisaki S, Nishio N, Tanaka M, Yoshida N, Matsumoto K, Kato K, Watanabe N, Kojima S.

Int J Hematol. 2012 Jun;95(6):675-9. doi: 10.1007/s12185-012-1079-9. Epub 2012 Apr 22.

PMID:
22527854
2.

Fanconi anemia (FA) binding protein FAAP20 stabilizes FA complementation group A (FANCA) and participates in interstrand cross-link repair.

Leung JW, Wang Y, Fong KW, Huen MS, Li L, Chen J.

Proc Natl Acad Sci U S A. 2012 Mar 20;109(12):4491-6. doi: 10.1073/pnas.1118720109. Epub 2012 Mar 6.

3.

Overcoming reprogramming resistance of Fanconi anemia cells.

Müller LU, Milsom MD, Harris CE, Vyas R, Brumme KM, Parmar K, Moreau LA, Schambach A, Park IH, London WB, Strait K, Schlaeger T, Devine AL, Grassman E, D'Andrea A, Daley GQ, Williams DA.

Blood. 2012 Jun 7;119(23):5449-57. doi: 10.1182/blood-2012-02-408674. Epub 2012 Feb 27.

4.

FAAP20: a novel ubiquitin-binding FA nuclear core-complex protein required for functional integrity of the FA-BRCA DNA repair pathway.

Ali AM, Pradhan A, Singh TR, Du C, Li J, Wahengbam K, Grassman E, Auerbach AD, Pang Q, Meetei AR.

Blood. 2012 Apr 5;119(14):3285-94. doi: 10.1182/blood-2011-10-385963. Epub 2012 Feb 17.

5.

Regulation of Rev1 by the Fanconi anemia core complex.

Kim H, Yang K, Dejsuphong D, D'Andrea AD.

Nat Struct Mol Biol. 2012 Jan 22;19(2):164-70. doi: 10.1038/nsmb.2222.

6.

The promise of induced pluripotent stem cells in research and therapy.

Robinton DA, Daley GQ.

Nature. 2012 Jan 18;481(7381):295-305. doi: 10.1038/nature10761. Review.

7.

ATR-ATRIP kinase complex triggers activation of the Fanconi anemia DNA repair pathway.

Shigechi T, Tomida J, Sato K, Kobayashi M, Eykelenboom JK, Pessina F, Zhang Y, Uchida E, Ishiai M, Lowndes NF, Yamamoto K, Kurumizaka H, Maehara Y, Takata M.

Cancer Res. 2012 Mar 1;72(5):1149-56. doi: 10.1158/0008-5472.CAN-11-2904. Epub 2012 Jan 18.

8.

Treatment of the bone marrow failure in Fanconi anemia patients with danazol.

Scheckenbach K, Morgan M, Filger-Brillinger J, Sandmann M, Strimling B, Scheurlen W, Schindler D, Göbel U, Hanenberg H.

Blood Cells Mol Dis. 2012 Feb 15;48(2):128-31. doi: 10.1016/j.bcmd.2011.11.006. Epub 2011 Dec 16.

PMID:
22178060
9.

Fanconi anemia.

Soulier J.

Hematology Am Soc Hematol Educ Program. 2011;2011:492-7. doi: 10.1182/asheducation-2011.1.492. Review.

PMID:
22160080
10.

Formaldehyde catabolism is essential in cells deficient for the Fanconi anemia DNA-repair pathway.

Rosado IV, Langevin F, Crossan GP, Takata M, Patel KJ.

Nat Struct Mol Biol. 2011 Nov 13;18(12):1432-4. doi: 10.1038/nsmb.2173.

PMID:
22081012
11.

Human MutS and FANCM complexes function as redundant DNA damage sensors in the Fanconi Anemia pathway.

Huang M, Kennedy R, Ali AM, Moreau LA, Meetei AR, D'Andrea AD, Chen CC.

DNA Repair (Amst). 2011 Dec 10;10(12):1203-12. doi: 10.1016/j.dnarep.2011.09.006. Epub 2011 Oct 4.

PMID:
21975120
12.

Structure of the FANCI-FANCD2 complex: insights into the Fanconi anemia DNA repair pathway.

Joo W, Xu G, Persky NS, Smogorzewska A, Rudge DG, Buzovetsky O, Elledge SJ, Pavletich NP.

Science. 2011 Jul 15;333(6040):312-6. doi: 10.1126/science.1205805.

13.

Mechanism of RAD51-dependent DNA interstrand cross-link repair.

Long DT, Räschle M, Joukov V, Walter JC.

Science. 2011 Jul 1;333(6038):84-7. doi: 10.1126/science.1204258.

14.

Fanconi anemia (FA)-associated 3q gains in leukemic transformation consistently target EVI1, but do not affect low TERC expression in FA.

Meyer S, Bristow C, Wappett M, Pepper S, Whetton AD, Hanenberg H, Neitzel H, Wlodarski MW, Ebell W, Tönnies H.

Blood. 2011 Jun 2;117(22):6047-50. doi: 10.1182/blood-2011-03-343897. No abstract available.

15.

The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations.

Myers K, Davies SM, Harris RE, Spunt SL, Smolarek T, Zimmerman S, McMasters R, Wagner L, Mueller R, Auerbach AD, Mehta PA.

Pediatr Blood Cancer. 2012 Mar;58(3):462-5. doi: 10.1002/pbc.23168. Epub 2011 May 5.

PMID:
21548014
16.

Diagnostic Overlap between Fanconi Anemia and the Cohesinopathies: Roberts Syndrome and Warsaw Breakage Syndrome.

van der Lelij P, Oostra AB, Rooimans MA, Joenje H, de Winter JP.

Anemia. 2010;2010:565268. doi: 10.1155/2010/565268. Epub 2010 Jul 18.

17.

Involvement of SLX4 in interstrand cross-link repair is regulated by the Fanconi anemia pathway.

Yamamoto KN, Kobayashi S, Tsuda M, Kurumizaka H, Takata M, Kono K, Jiricny J, Takeda S, Hirota K.

Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6492-6. doi: 10.1073/pnas.1018487108. Epub 2011 Apr 4.

18.

Diamond Blackfan anemia treatment: past, present, and future.

Narla A, Vlachos A, Nathan DG.

Semin Hematol. 2011 Apr;48(2):117-23. doi: 10.1053/j.seminhematol.2011.01.004. Review.

19.

Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions.

Quentin S, Cuccuini W, Ceccaldi R, Nibourel O, Pondarre C, Pagès MP, Vasquez N, Dubois d'Enghien C, Larghero J, Peffault de Latour R, Rocha V, Dalle JH, Schneider P, Michallet M, Michel G, Baruchel A, Sigaux F, Gluckman E, Leblanc T, Stoppa-Lyonnet D, Preudhomme C, Socié G, Soulier J.

Blood. 2011 Apr 14;117(15):e161-70. doi: 10.1182/blood-2010-09-308726. Epub 2011 Feb 16.

20.

SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype.

Stoepker C, Hain K, Schuster B, Hilhorst-Hofstee Y, Rooimans MA, Steltenpool J, Oostra AB, Eirich K, Korthof ET, Nieuwint AW, Jaspers NG, Bettecken T, Joenje H, Schindler D, Rouse J, de Winter JP.

Nat Genet. 2011 Feb;43(2):138-41. doi: 10.1038/ng.751. Epub 2011 Jan 16.

PMID:
21240277

Supplemental Content

Support Center